Narrowing the equity gap: The impact of organized versus opportunistic cancer screening in Catalonia (Spain)

Journal of Medical Screening

Volumn 18, Issue 2, 2011, Pages 87-90

  Espinas, Josep A ^a   Aliste, Luisa ^a   Fernandez, Esteve ^b   JosepM Argimon, ^c   Tresserras, Ricard ^d   Borras, Josep M ^b  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c C Agy Hlth Technol Assess Res   (Spain)

^d Catalan Hearth Service   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST TUMOR; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; FEMALE; HEALTH CARE DELIVERY; HUMAN; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; SPAIN; STATISTICS;

AGED; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; SPAIN;

EID: 80051906289     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2011.010086     Document Type: Article

References (29)

1. Izquierdo A, Gispert R, Saladie F, Espinas JA. Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985-2019: Breast cancer. Med Clin (Barc) 2008;131(Suppl 1):50-2
2. Vainio H, Bianchini F, eds. Breast Cancer Screening. IARC Handbooks of Cancer Prevention, Vol. 7. Lyon: IARC Press, 2002
3. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:716-26
4. Shapiro S, Coleman EA, Broeders M, et al. Breast cancer screening programmes in 22 countries: Current policies, administration and guidelines. Int J Epidemiol 1998;27:735-42 (Pubitemid 28504958)
5. IARC Working Group on the Evaluation of Cancer PreventionStrategies. Cervix Cancer Screening. IARC Handbooks of Cancer Prevention, Vol. 10. Lyon: IARCPress, 2005
6. European Comission. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. 4th edn. Luxembourg: Office for Official Publications of the European Communities, 2006
7. Arbyn M, Antilla A. European Guidelines for Quality Assurance in Cervical Screening. 2nd edn. IARC. Luxembourg: Office for Official Publications of the European Communities, 2008
8. Durán A, Lara JL, vanWaveren M. Spain: Health system review. Health Syst Transition 2006;8:1-208
9. Generalitat de Catalunya, Servei Català de la Salut. Enquesta de salut de Catalunya 1994. Barcelona: Departament de Sanitat i Seguretat Social, Servei Català de la Salut, 1996
10. Departament de Salut. Generalitat de Catalunya. Enquesta de salut de Catalunya (ESCA) 2006. Barcelona: Departament de Salut, 2006
11. Guillen M, Junca S, Rue M, Aragay JM. [Effect of sample design in the analysis of complex surveys. Application to the health survey of Catalonia]. Gac Sanit 2000;14:399-402
12. Borrell C, Rue M, Pasarin I, Benach J, Kunst E. [The measurement of inequalities in health]. Gac Sanit 2000;14:20-33
13. Schiaffino A, Rodríguez M, Pasarín MI, et al. [Odds ratio or prevalence ratio? Their use in cross-sectional studies]. Gac Sanit 2003;17:70-4
14. Kunst AE, Mackenbach JP. Measuring Socioeconomic Inequalities in Health. Copenhagen: WHO, Region Office for Europe, 1994
15. Schneider MC, Castillo-Salgado C, Bacallao J, et al. Methods for measuring inequalities in health. Rev Panam Salud Publica 2002;12:398-414 (Pubitemid 36168176)
16. Madlensky L, Goel V, Polzer J, Ashbury FD. Assessing the evidence for organised cancer screening programmes. Eur J Cancer 2003;39:1648-53 (Pubitemid 36897600)
17. Segnan N. Socioeconomic status and cancer screening. In: Kogevinas M, Pearce N, Susser M, Boffetta P, eds. Social Inequalities and Cancer. IARC Scientific Publication No. 138. Lyon: International Agency for Research on Cancer, 1997:369-76
18. van Ballegooijen M, van den Akker-van Marle E, Patnick J, et al. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 2000;36:2177-88
19. Adab P, McGhee SM, Yanova J, Wong CM, Hedley AJ. Effectiveness and efficiency of opportunistic cervical cancer screening: Comparison with organized screening. Med Care 2004;42:600-9
20. Palencia L, Espelt A, Rodriguez-Sanz M, et al. Socio-economic inequalities in breast and cervical cancer screening practices in Europe: Influence of the type of screening program. Int J Epidemiol 2010;39:757-65
21. O'Byrne AM, Kavanagh AM, Ugoni A, Diver F. Predictors of non-attendance for second round mammography in an Australian mammographic screening programme. J Med Screen 2000;7:190-4 (Pubitemid 32099056)
22. Zackrisson S, Andersson I, Manjer J, Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 2004;108:754-60 (Pubitemid 38076408)
23. Moser K, Patnick J, Beral V. Inequalities in reported use of breast and cervical screening in Great Britain: Analysis of cross sectional survey data. BMJ 2009;338:b2025
24. Arblaster L, Lambert M, Entwistle V, et al. A systemathic review of the effectiveness of health service intervention aimed at reducing inequalitis in health. J Health Serv Res Policy 1996;1:93-103 (Pubitemid 26411149)
25. Birch S, Haas M, Savage E, van Gool K. Targeting services to reduce social inequalities in utilisation: An analysis of breast cancer screening in New South Wales. ANZ Health Policy 2007;4:12
26. Puig-Tintore LM, Castellsague X, Torne A, et al. Coverage and factors associated with cervical cancer screening: Results from the AFRODITA study: A population-based survey in Spain. J Low Genit Tract Dis 2008;12:82-9 (Pubitemid 351457912)
27. Weller DP, Patnick J, McIntosh HM, Dietrich AJ. Uptake in cancer screening programmes. Lancet Oncol 2009;10:693-9
28. Howard M, Agarwal G, Lytwyn A. Accuracy of self-reports of Pap and mammography screening compared to medical record: A meta-analysis. Cancer Causes Control 2009;20:1-13
29. Borras JM, Colomer C, Soria P, Lopez R. Priorities for cancer control in Spain. Ann Oncol 2010;21(Suppl 3):ii111-4